Activation and coagulation biomarkers were measured within the Strategies for Management of Antiretroviral Therapy (SMART) trial. Their associations with opportunistic disease (OD) in human immunodeficiency virus (HIV)-positive patients were examined.
HIV Epidemiology and Biostatistics Group, Research Dept. of Infection and Population Health, UCL Medical School, University College London, London, UK. a.rodger@pcps.ucl.ac.uk
